Literature DB >> 8199782

Outcome of depression in psychiatric settings.

M Piccinelli1, G Wilkinson.   

Abstract

We reviewed follow-up studies of adults with depressive disorders seen in psychiatric settings, and noted outcomes in terms of recovery, recurrence, and persistent depression, at six months, one year, two to five years, and ten or more years after an index episode of depression. Recovery increased with time: about half recovered at least briefly by six months, and a large majority did so in the long term. Only about a quarter recovered from an index episode and remained well more than ten years thereafter. A quarter of patients suffered recurrence of depression within a year of an index episode, and three-quarters did so at least once during follow-up periods lasting more than ten years. For more than one in ten patients, the depression proved persistent, the proportion affected remaining relatively stable over time. The review highlighted a relative paucity of conclusive investigations on the outcome of the commonest psychiatric disorder in clinical settings.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8199782     DOI: 10.1192/bjp.164.3.297

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  18 in total

1.  Assessment of subclinical symptoms and psychological well-being in depression.

Authors:  G A Fava; L Mangelli
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2001       Impact factor: 5.270

Review 2.  Putting trials on trial--the costs and consequences of small trials in depression: a systematic review of methodology.

Authors:  M Hotopf; G Lewis; C Normand
Journal:  J Epidemiol Community Health       Date:  1997-08       Impact factor: 3.710

3.  The gastrointestinal tract microbiome, probiotics, and mood.

Authors:  Luis Vitetta; Matthew Bambling; Hollie Alford
Journal:  Inflammopharmacology       Date:  2014-09-30       Impact factor: 4.473

4.  Depression in the Primary Care Setting. Reply.

Authors:  Lawrence T Park; Carlos A Zarate
Journal:  N Engl J Med       Date:  2019-06-06       Impact factor: 91.245

Review 5.  Paroxetine: a review.

Authors:  M Bourin; P Chue; Y Guillon
Journal:  CNS Drug Rev       Date:  2001

6.  Increased incidence of CYP2D6 gene duplication in patients with persistent mood disorders: ultrarapid metabolism of antidepressants as a cause of nonresponse. A pilot study.

Authors:  Chiaki Kawanishi; Stefan Lundgren; Hans Agren; Leif Bertilsson
Journal:  Eur J Clin Pharmacol       Date:  2003-12-02       Impact factor: 2.953

Review 7.  Treatment of recurrent depression: a sequential psychotherapeutic and psychopharmacological approach.

Authors:  Giovanni A Fava; Chiara Ruini; Nicoletta Sonino
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

8.  Course and outcome of acute non-organic psychotic states in India.

Authors:  V K Varma; S Malhotra; E S Yoo; R C Jiloha; M T Finnerty; E Susser
Journal:  Psychiatr Q       Date:  1996

9.  The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods.

Authors:  Brenda W J H Penninx; Aartjan T F Beekman; Johannes H Smit; Frans G Zitman; Willem A Nolen; Philip Spinhoven; Pim Cuijpers; Peter J De Jong; Harm W J Van Marwijk; Willem J J Assendelft; Klaas Van Der Meer; Peter Verhaak; Michel Wensing; Ron De Graaf; Witte J Hoogendijk; Johan Ormel; Richard Van Dyck
Journal:  Int J Methods Psychiatr Res       Date:  2008       Impact factor: 4.035

10.  Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo.

Authors:  P F Sullivan; E J C de Geus; G Willemsen; M R James; J H Smit; T Zandbelt; V Arolt; B T Baune; D Blackwood; S Cichon; W L Coventry; K Domschke; A Farmer; M Fava; S D Gordon; Q He; A C Heath; P Heutink; F Holsboer; W J Hoogendijk; J J Hottenga; Y Hu; M Kohli; D Lin; S Lucae; D J Macintyre; W Maier; K A McGhee; P McGuffin; G W Montgomery; W J Muir; W A Nolen; M M Nöthen; R H Perlis; K Pirlo; D Posthuma; M Rietschel; P Rizzu; A Schosser; A B Smit; J W Smoller; J-Y Tzeng; R van Dyck; M Verhage; F G Zitman; N G Martin; N R Wray; D I Boomsma; B W J H Penninx
Journal:  Mol Psychiatry       Date:  2008-12-09       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.